Gilead Therapeutics A1 Unlimited Co

CIK 2055207 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Gilead Therapeutics A1 Unlimited Co.

Recent SEC filings

FiledFormAccession number
Aug 26, 2026N-PX0001123292-26-001173
Aug 3, 202613F-NT0001123292-26-001038
May 8, 202613F-NT0001123292-26-000643
Feb 12, 202613F-NT0001123292-26-000165
Nov 13, 202513F-NT0001123292-25-000641
Aug 29, 2025N-PX0001021408-25-004366
Aug 14, 202513F-NT0001123292-25-000363
May 13, 202513F-NT0001123292-25-000216
Feb 13, 202513F-NT0001123292-25-000080